The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.

The co-founders of Fred Hutch's oncology therapeutics developer include Philip Greenberg who previously helped launch Juno Therapeutics.

The corporate card provider was valued at $2.1bn in a round backed by Stanford University that increased its funding to $380m altogether.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Triumvera, co-founded by McMaster's professor Jonathan Bramson, looks to progress its solid tumour therapeutic candidate.

UC Berkeley spinout SiFive has fetched a $2.5bn valuation in a series F round that pushed its overall financing to more than $350m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.